Exact Mass: 526.1161
Exact Mass Matches: 526.1161
Found 181 metabolites which its exact mass value is equals to given mass value 526.1161
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bromadiolone
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins D010575 - Pesticides > D012378 - Rodenticides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 3656
Salcolin A
rel-(7R,8S)-(2,4,4,5-tetrahydroxychalcone)-(2->7,8->8)-2,4,4-trihydroxy-7,8-dihydrochalcone|urundeuvine C
20-O-beta-glucopyranosyl-18-hydroxycamptothecin|20-O-??-Glucopyranosyl 18-hydroxycamptothecin
8-O-[beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranosyl]-8-hydroxybergapten
7-[(2-O-acetyl-beta-glucopyranosyl)oxy]-7-hydroxy-[8,8-bi-2H-1-benzopyran]-2,2-dione
lycopodone|rel-(7R, 8S)-tricin-4-O-(4-hydroxy-3-methoxyphenyl propanetriol)
3,5,10,11-Tetrahydroxy-9-methoxy-13-(4-methoxybenzyl)-13H-8-oxabenzo[a]naphthacene-7,14-dione
2-[(benzoyloxy)methyl]-4-hydroxyphenyl-beta-D-glucopyranoside 3-(4-hydroxybenzoate)|symponoside
3-(2,4-dihydroxybenzoyl)-2,3-dihydro-4,6-dihydroxy-2-(4-hydroxyphenyl)-1-benzofuran-7-yl 2-(4-hydroxyphenyl)ethenyl ketone
alpha-Resorcyclic acid-mono-beta-D-glucoside peracetate
3-methoxy-2,4-di-O-methylgyrophoric acid|3-Methoxy-2,4-di-O-methylgyrophric acid
Patentiflorin A
Patentiflorin A is a natural product found in Justicia patentiflora with data available.
Flavone base + 3O, 2MeO, O-guaiacylglycerol
Annotation level-3
Asp Asp Asp Tyr
Asp Asp Tyr Asp
Asp Met Met Met
Asp Tyr Asp Asp
Met Asp Met Met
Met Met Asp Met
Met Met Met Asp
Tyr Asp Asp Asp
3-Carboxy-1-hydroxypropyl-THPP
Larotrectinib Sulfate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155765 - TRK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
1,3-diphenyl-1,1,3,3-tetrakis(dimethylsiloxy)disiloxane
1,3-BIS(CHLOROMETHYL)-1,1,3,3-TETRAKIS(TRIMETHYLSILOXY)DISILOXANE
N-(2,6-Dichlorobenzoyl)-4-[1,6-Dimethyl-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-Yl]-L-Phenylalanine
2-[4-[(Z)-[5-(4-chlorophenyl)-7-methyl-3-oxo-6-propan-2-yloxycarbonyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-2-ylidene]methyl]phenoxy]acetic acid
(-)-(7R,8S)-4,5,7-trihydroxy-3,3,5-trimethoxy-4,8-oxyflavonolignan-7,9-diol
A flavonolignan isolated from the stems of natural product found in Sinocalamus affinis.
(-)-(7S,8S)-4,5,7-trihydroxy-3,3,5-trimethoxy-4,8-oxyflavonolignan-7,9-diol
A flavonolignan isolated from the stems of Sinocalamus affinis.
4-chloro-N-[3-(4-fluorophenyl)-5-[2-(4-methoxyanilino)-2-oxoethyl]-4-oxo-2-sulfanylidene-1-imidazolidinyl]benzamide
7-[[2-[5-Cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
17beta-estradiol 17-O-(3-sulfo-beta-D-glucuronate)
17beta-estradiol 3-O-(beta-D-glucuronate) 17-sulfate
4-fluoro-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
4-fluoro-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
4-Methyl-2-oxochromen-7-yl {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-4-oxochromen-7-yl]oxy}acetate
A carboxylic ester obtained by formal condensation of that carboxy group of {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-4-oxochromen-7-yl]oxy}acetic acid with the hydroxy group of 7-hydroxy-4-methylchromen-2-one.
6-[2-(8,8-Dimethyl-2-oxopyrano[2,3-]chromen-3-yl)-5-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
[2-[5,7-Dihydroxy-2-(4-methoxyphenyl)-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] hydrogen sulate
(2S,3R,4S,5R,6S)-3,5-dihydroxy-6-[[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-sulfooxyoxane-2-carboxylic acid
Mycro 3
Mycro 3 is an orally active, potent and selective inhibitor of Myc-associated factor X (MAX) dimerization. Mycro 3 also inhibit DNA binding of c-Myc[1]. Mycro 3 could be used for the research of pancreatic cancer[2].